FreshBlood Health Market Consultants, which was launched in 2015 by prominent healthcare industry marketing expert Robert Finkel, announced the life-science solutions provider’s expanded creative services capabilities and official reconfiguration as FreshBlood Group.
Months after securing $72 million in a Series C financing round and expanding a developmental agreement with pharma giant Roche worth up to $1 billion, SQZ Biotech is expanding the company’s footprint in Watertown, Mass.
Regeneron plans to invest more than $800 million over seven years to expand the company’s facilities in Rensselaer County, New York. This expansion is expected to create 1,500 new full-time jobs.
Backed by financing from a collaboration with Novartis and an $83 million financing round, Homology Medicines is moving to a new facility with more than triple the space of its headquarters.
W2O Group, a network of innovative analytics-driven, digital-first marketing and communications firms, announced the appointment of three senior executives in its growing Chicago office.
Precision Value & Health announced the formation of Precision Xtract – a new, focused alignment of the company’s global market access consulting services.
Pfizer reportedly chose a site for the company’s new headquarters, the as-yet constructed Manhattan skyscraper The Spiral.
Germany-based Fresenius Kabi, part of Fresenius SE & Co. KGaA, slapped down $4.3 billion to acquire Illinois-based Akorn Inc. and a larger toehold in the United States.
Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States
Advanced R&D, Manufacturing, and Packaging Facility to Serve as U.S. Headquarters; Initially Expected to Create Minimum of 150 Full-Time Jobs BROWARD COUNTY, Fla., March 8, 2017 /PRNewswire/ — Today Apotex Inc., the largest Canadian owned pharmaceutical company, announced the details of a $184 million U.S. expansion plan, including the development of a new R&D center […]
Pfizer has its eyes set on a possible $100 million investment to expand a plant in Sanford, N.C. with a focus on gene therapy, according to the Triangle Business Journal. The investment would include the addition of 50 new jobs.